UBS Group’s Avita Medical RCEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.17M | Buy |
409,799
+65,071
| +19% | +$344K | ﹤0.01% | 3772 |
|
|
2025
Q1 | $2.81M | Buy |
344,728
+216,098
| +168% | +$1.76M | ﹤0.01% | 3454 |
|
|
2024
Q4 | $1.65M | Buy |
128,630
+110,824
| +622% | +$1.42M | ﹤0.01% | 3877 |
|
|
2024
Q3 | $191K | Buy |
17,806
+686
| +4% | +$7.35K | ﹤0.01% | 4734 |
|
|
2024
Q2 | $136K | Sell |
17,120
-34,396
| -67% | -$272K | ﹤0.01% | 4824 |
|
|
2024
Q1 | $826K | Buy |
51,516
+31,509
| +157% | +$505K | ﹤0.01% | 3686 |
|
|
2023
Q4 | $274K | Buy |
20,007
+7,258
| +57% | +$99.6K | ﹤0.01% | 4403 |
|
|
2023
Q3 | $186K | Sell |
12,749
-4,729
| -27% | -$69.1K | ﹤0.01% | 4307 |
|
|
2023
Q2 | $297K | Buy |
17,478
+11,470
| +191% | +$195K | ﹤0.01% | 4190 |
|
|
2023
Q1 | $83.9K | Buy |
6,008
+5,282
| +728% | +$73.8K | ﹤0.01% | 4987 |
|
|
2022
Q4 | $4.79K | Buy |
726
+476
| +190% | +$3.14K | ﹤0.01% | 8080 |
|
|
2022
Q3 | $1K | Sell |
250
-1,023
| -80% | -$4.09K | ﹤0.01% | 8908 |
|
|
2022
Q2 | $6K | Sell |
1,273
-136
| -10% | -$641 | ﹤0.01% | 7669 |
|
|
2022
Q1 | $13K | Sell |
1,409
-35,820
| -96% | -$330K | ﹤0.01% | 7019 |
|
|
2021
Q4 | $445K | Buy |
37,229
+21,042
| +130% | +$252K | ﹤0.01% | 4068 |
|
|
2021
Q3 | $287K | Buy |
16,187
+14,987
| +1,249% | +$266K | ﹤0.01% | 4049 |
|
|
2021
Q2 | $25K | Sell |
1,200
-12,922
| -92% | -$269K | ﹤0.01% | 6024 |
|
|
2021
Q1 | $280K | Buy |
14,122
+12,271
| +663% | +$243K | ﹤0.01% | 4295 |
|
|
2020
Q4 | $35K | Buy |
1,851
+1,651
| +826% | +$31.2K | ﹤0.01% | 5505 |
|
|
2020
Q3 | $5K | Sell |
200
-959
| -83% | -$24K | ﹤0.01% | 6444 |
|
|
2020
Q2 | $35K | Buy |
1,159
+959
| +480% | +$29K | ﹤0.01% | 5330 |
|
|
2020
Q1 | $6K | Sell |
200
-871
| -81% | -$26.1K | ﹤0.01% | 6309 |
|
|
2019
Q4 | $49K | Buy |
+1,071
| New | +$49K | ﹤0.01% | 5312 |
|